Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes

NCT01342484 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: placebo
DRUG: BI1356 low dose
DRUG: BI1356 high dose

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]